Invatec launches the IN.PACT Amphirion drug-eluting balloon


Invatec has announced the European launch of a new peripheral balloon, the IN.PACT Amphirion paclitaxel-eluting percutaneous transluminal angioplasty balloon catheter. This is the first drug-eluting catheter designed specifically to treat atherosclerosis in arteries located below the knee. IN.PACT features FreePac, a proprietary coating that frees and separates paclitaxel molecules and facilitates their absorption into the wall of the artery. The FreePac coating was developed in close collaboration with the researchers who pioneered drug-eluting balloon therapy, Ulrich Speck, Charité Berlin, Germany, and Bruno Scheller, University Hospital, Homburg/Saar, Germany.

Invatec plans to launch a randomised trial, the IN.PACT DEEP study, in the first half of 2009, to provide additional data about the effectiveness of this new treatment concept.